Skip to content

Clinical trials

Phase 3 Carcinoma in Situ trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma in Situ Phase: Phase 3 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20101
20111
20151
20161
20171
20201
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2
Active, not recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bioniche Life Sciences Inc.1
CG Oncology, Inc.1
Children's Oncology Group1
Endo USA Inc., a Keenova Therapeutics Company1
Institut Claudius Regaud1
Johannes Gutenberg University Mainz1
M.D. Anderson Cancer Center1
Medical Enterprises Europe B.V.1
Protara Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma in Situ9
Neoplasms4
Non-Muscle Invasive Bladder Neoplasms4
Urinary Bladder Neoplasms4
Carcinoma, Transitional Cell2
Neoplasms by Site2
Urinary Bladder Diseases2
Urogenital Neoplasms2
Urologic Diseases2
Urologic Neoplasms2

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.